TY - JOUR T1 - Risk of Venous Thromboembolism in Ankylosing Spondylitis and Rheumatoid Arthritis: Genetic Aspects JF - The Journal of Rheumatology JO - J Rheumatol SP - 1492 LP - 1493 DO - 10.3899/jrheum.210131 VL - 48 IS - 9 AU - George N. Goulielmos AU - Maria I. Zervou Y1 - 2021/09/01 UR - http://www.jrheum.org/content/48/9/1492.abstract N2 - To the Editor:In the postgenomic era, the genomic revolution in translational medicine has not escaped the attention of clinicians and researchers focusing on the medical management of venous thromboembolism (VTE). VTE, a multifactorial disease, is a worldwide health problem affecting people of all ages, sexes, and races, and has 2 major subtypes: deep vein thrombosis and pulmonary embolism.1 The clinical outcomes of VTE represent the major source of morbidity and mortality. No extended data related to the comorbidities of autoimmune diseases with VTE have been presented thus far. Recently, Molander, et al2 conducted a nationwide register-based cohort study and demonstrated a strong association between clinical rheumatoid arthritis (RA) disease activity and the risk of VTE. Moreover, Aviña-Zubieta, et al3 conducted a highly informative to the researchers cohort study in Canada, wherein the overall incidence of VTE was 2.03-fold higher in people with … ER -